Calliditas Therapeutics AB (CALT)
40.00
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
Calliditas Therapeutics 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
September 27, 2024 | 115.3% |
September 26, 2024 | 119.0% |
September 25, 2024 | 115.8% |
September 24, 2024 | 117.0% |
September 23, 2024 | 117.0% |
September 20, 2024 | 144.2% |
September 19, 2024 | 147.9% |
September 18, 2024 | 131.8% |
September 17, 2024 | 150.5% |
September 16, 2024 | 155.3% |
September 13, 2024 | 150.2% |
September 12, 2024 | 146.0% |
September 11, 2024 | 152.8% |
September 10, 2024 | 153.7% |
September 09, 2024 | 153.7% |
September 06, 2024 | 152.8% |
September 05, 2024 | 145.6% |
September 04, 2024 | 146.7% |
September 03, 2024 | 153.4% |
August 30, 2024 | 141.3% |
August 29, 2024 | 141.0% |
August 28, 2024 | 137.4% |
August 27, 2024 | 140.3% |
August 26, 2024 | 139.3% |
August 23, 2024 | 127.4% |
Date | Value |
---|---|
August 22, 2024 | 130.4% |
August 21, 2024 | 132.5% |
August 20, 2024 | 146.4% |
August 19, 2024 | 142.3% |
August 16, 2024 | 107.5% |
August 15, 2024 | 100.7% |
August 14, 2024 | 92.39% |
August 13, 2024 | 103.3% |
August 12, 2024 | 103.0% |
August 09, 2024 | 107.0% |
August 08, 2024 | 113.6% |
August 07, 2024 | 127.9% |
August 06, 2024 | 121.4% |
August 05, 2024 | 121.1% |
August 02, 2024 | 121.3% |
August 01, 2024 | 100.4% |
July 31, 2024 | 95.38% |
July 30, 2024 | 110.4% |
July 29, 2024 | 109.8% |
July 26, 2024 | 116.6% |
July 25, 2024 | 120.3% |
July 24, 2024 | 124.8% |
July 23, 2024 | 131.9% |
July 22, 2024 | 133.1% |
July 19, 2024 | 132.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-54.16%
Minimum
May 09 2022
155.3%
Maximum
Sep 16 2024
7.39%
Average
-5.21%
Median
1 Year Total Returns (Daily) Benchmarks
Abliva AB | 0.00% |
NuCana PLC | -84.20% |
Karolinska Development AB | -- |
Oncopeptides AB | -55.83% |
TC BioPharm (Holdings) PLC | -98.87% |